DPP4 and obesity disorder: Importantly, the DPP4 inhibitor linagliptin induced a reciprocal decrease in M1 macrophages and an increase in M2 macrophages in white adipose tissue and liver tissue of mice, resulting in attenuation of obesity-induced inflammation and insulin resistance [77].